98%
921
2 minutes
20
The contribution of bone resorption to fetal calcium demand during pregnancy is still unclear due to the methods used to study bone turnover. Recently, bone mineral density (BMD) was measured in the third trimester of pregnancy using radiofrequency echographic multi-spectrometry (REMS) technology, a nonionizing technique. Thus, the present study aimed to determine changes in maternal BMD during pregnancy in healthy women using REMS. A prospective cohort study was conducted among 164 pregnant women. Femoral neck BMD was determined in all patients once in each trimester by REMS densitometry. Lifestyle and demographic data were collected by interview. Previous reports in postmenopausal women identified two subpopulations based on the annual rate of bone loss; thus, the bone loss group was stratified into slow and fast bone loser groups. BMD was significantly lower in the second and third trimesters compared with the first trimester. A wide interindividual variation in BMD change was observed; therefore, women were stratified into two groups: bone loss ( = 136) and bone gain ( = 28) according to the rate of BMD loss or gain from the first to third trimester. Binary logistic regression revealed that no calcium + vitamin D and no multivitamin intake were independent factors significantly associated with bone loss at the end of pregnancy. Fisher's exact test revealed a significant association between gravidity and fast bone loss. Decreased BMD during pregnancy is associated with no multivitamin intake and no calcium + vitamin D intake. In addition, fast bone loss is associated with the number of pregnancies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/15409996251372853 | DOI Listing |
PLoS Comput Biol
September 2025
Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Fanconi Anemia (FA) is a heritable syndrome characterized by DNA damage repair deficits, frequent malformations and a significantly elevated risk of bone marrow failure, leukemia, and mucosal head and neck squamous cell carcinomas (HNSCC). Hematopoietic stem cell gene therapy can prevent marrow failure and lower leukemia risk, but mucosal gene therapy to lower HNSCC risk remains untested. Major knowledge gaps include an incomplete understanding of how rapidly gene-corrected cellular lineages could spread through the oral epithelium, and which delivery parameters are critical for ensuring efficient gene correction.
View Article and Find Full Text PDFEur J Orthop Surg Traumatol
September 2025
All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar, India.
Background: Pelvic and acetabular fractures, often resulting from high-impact trauma, pose significant challenges due to extensive blood loss and complex surgical procedures. Tranexamic acid (TXA), widely used in elective orthopedic surgeries, offers a potential strategy for managing blood loss. However, its efficacy and safety in pelvic-acetabular trauma surgeries have shown inconsistent results in prior studies.
View Article and Find Full Text PDFCurr Sports Med Rep
September 2025
Department of Orthopaedics, University of North Carolina School of Medicine, Chapel Hill, NC.
Glenohumeral instability is a common injury affecting contact and collision athletes. Male sex, younger age at time of first dislocation, and contact sports participation are risk factors for recurrent instability. MRI is the gold standard to evaluate soft tissue structures, while CT is beneficial in quantifying glenoid bone loss and identifying on-track and off-track Hill-Sachs lesions.
View Article and Find Full Text PDFAdv Mater
September 2025
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Bone defect therapy frequently encounters bacterial infections and chronic inflammation, which impair bone regeneration and threaten implant stability. Iron oxide nanoparticles have attracted attention due to cost-effectiveness, biocompatibility, and metabolic safety. However, iron oxide nanoparticles still struggle to balance low-temperature efficient antibacterial activity, effective immunomodulation, and bone regeneration.
View Article and Find Full Text PDFBackground: Anticonvulsants are widely used in treating patients with mental and neurological disorders. Their long-term use increases the risk of a decrease in bone mineral density (BMD) and low-energy fractures. Despite the growing number of studies of drug-induced osteoporosis, the effect of anticonvulsants on bone microarchitecture remains poorly studied.
View Article and Find Full Text PDF